E N D
1. Lecture 6 amino acid NTsGABA Glutamate
3. Glutamate the principal excitatory NT in the brain -
used in about 20% of synaptic connections between neurons
MSG = monosodium glutamate
some people experience mild neurological symptoms (dizziness, numbness) after eating food containing high levels of MSG
4. Glutamate there are different sub-types of glutamate receptor, but the most studied is the NMDA (N-methyl-D-aspartate) receptor -
important role in learning & memory responsible for initiating long-term changes in the brain associated with memory formation,
also implicated in drug addiction (especially alcoholism),
and in schizophrenia
5. NMDA receptor antagonists inhibit excitatory effects of glutamate
ketamine & phencyclidine (PCP) -
have sedative & anaesthetic effects at high doses
hallucinogenic & dissociative effects at lower doses
low dose effects replicate both positive and negative symptoms of schizophrenia
alcohol also acts as an NDMA antagonist
6. Ketamine & PCP early studies with PCP showed it could produce an extended psychotic breakdown in some individuals, and this drug is no longer used in human research
ketamine is used in research with human subjects although its acute effects are similar, they are less intense and have a shorter duration; adverse reactions are rare and follow-up of participants show no long-term effects (Perry et al, 2007)
7. Acute effects of ketamine feeling drunk- euphoria, dizziness, nausea
disordered thought and speech
memory impairment
perceptual distortions and dissociation-objects and surroundings seem unreal
delusional thinking - often of a paranoid nature
8. Brief Psychiatric Rating Scale (BPRS) Instructions:
Circle the number that best describes the patients present condition. If a specific symptom is not being assessed, circle NA.
1 = not present
2 = very mild
3 = mild
4 = moderate
5 = moderately severe
6 = severe
7 = extremely severe
9. BPRS scores during double-blind placebo-controlled intravenous ketamine infusion (Newcomer et al, 1999)
10. Ketamine & memory studies consistently show impairment of episodic memory following sub-anaesthetic doses of ketamine, across a wide variety of tasks
recognition memory, recall of spoken prose, recall of word lists, spatial learning, source memory tasks
11. GABA the principal inhibitory NT in the brain -
used in about 40% of synaptic connections between neurons
GABA receptors are complex -
binding sites for different chemicals on the same receptor
13. GABA agonists benzodiazepines, barbiturates & alcohol all enhance the inhibitory effects of GABA
these drugs all have anxiolytic, sedative & hypnotic effects
i.e. they reduce anxiety, produce physical relaxation & promote sleep
14. GABA antagonists picrotoxin a poisonous plant alkaloid with stimulant properties
flumazenil benzodiazepine antidote
blocks benzodiazepine site binds but does not activate
used to treat overdose, and to reverse the sedative effects of benzodiazepines in post-operative patients
15. Anxiolytics anxiolytic = drug used to reduce anxiety
barbiturates are direct GABA receptor agonists bind to and activate GABA receptors
benzodiazepines do not directly activate GABA receptors they enhance the effects of endogenous GABA, but GABA must also bind to receptor for drug to have effect
16. Barbiturates amobarbital, pentobarbital, secobarbital, phenobarbital, etc.
first available in 1903 (Barbital)
euphoric effects of these drugs mean they have high potential for abuse, dependence & addiction
increasing dose leads to increased central nervous system depression
sedation ? sleep ? coma ? death
pronounced respiratory depression (especially when mixed with alcohol) means high risk of fatal overdose
17. Benzodiazepines first available in 1960 (Librium)
have replaced barbiturates in treatment of anxiety disorders and insomnia -
produce less respiratory depression
have pronounced sedative effect, but less euphoric
lower incidence of dependence (but may still occur in 10-30% of long-term users)
18. Benzodiazepines many different benzodiazepines (BDZs) are now available -
diazepam (Valium), temazepam (Restoril), lorazepam (Ativan, Temesta), alprazolam (Xanax), midazolam (Dormicum), etc.
these differ in potency, primary effect (anxiolytic, hypnotic, muscle relaxant), time to produce effect, and duration of effect
19. Benzodiazepines the most commonly prescribed psychotropic drugs in the world
estimated 20-30% of adult population are prescribed BDZ at some time
up to 5% of adult population on long-term (one year or more) prescriptions
used in treatment of anxiety disorders, insomnia, drug & alcohol withdrawal
also used as pre-anaesthetics & muscle-relaxants in surgical operations
20. Benzodiazepines side-effects
drowsiness (e.g. following day when BDZ is used for insomnia)
impaired motor co-ordination & balance
slowed reaction times
impaired vigilance task performance
impaired memory performance
21. Benzodiazepines & memory effects are found mainly for long-term episodic memory short-term memory is less affected & semantic memory is generally intact (see Curran, 1999)
studies consistently show anterograde amnesia i.e. memory impairment for information presented after the drug has been administered
but not retrograde amnesia i.e. no impairment for information learned before drug administration
suggests impairment of encoding processes rather than retrieval
22. Measuring drug effects in on-the-road driving (Verster et al 2005, Current Psychiatry Reviews 1, 215-225)
23. Alprazolam (Xanax) & driving - Verster et al (2002) (A) Weaving (SDLP) (B) Speed variability
24. Alcohol
25. alcohol = any drink containing ethanol (ethyl alcohol)
produced by fermentation (conversion of sugar to alcohol by yeast)
probably the oldest recreational drug - archaeological evidence for beer & wine since about 10,000 years
acute subjective effects of alcohol are biphasic -
low doses are mildly stimulating
high doses have the opposite effect i.e. are sedating or depressant
26. Biphasic effect of alcohol BAL (U.S.) measured in grams of alcohol per 100ml of blood
BAC measured in grams per litre, or mg per 100ml (U.K.)
U.K. legal driving limit = .08g/100ml (BAL) = 0.8g/l = 80mg/100ml
27. Alcohol & neurotransmitters alcohol is a pharmacologically messy drug
acute effects on NT systems are wide-ranging and complex -
increases inhibitory NT activity (GABA) &
decreases excitatory NT activity (glutamate)
this causes knock-on effects on other NT systems throughout the entire brain
28. Alcohol abuse & dependence chronic alcohol abuse leads to adaptations in physiological processes that act in opposition to drug effects in order to maintain homeostasis
sudden withdrawal of alcohol leads to rebound effects, which are opposite to the effects of drug
these are experienced as an unpleasant withdrawal syndrome, which can only be alleviated by reinstating alcohol use
so individual becomes dependent on alcohol for normal functioning
29. Opponent processes in alcohol abuse(see Valenzuela, 1997)
30. acute withdrawal effects in long-term alcoholics
anxiety, delirium, hallucinations & potentially fatal seizures
these reflect state of excessive neural excitation
alcohol withdrawal symptoms are reduced by administering benzodiazepines (to enhance inhibitory GABA-ergic activity)
31. Alcohol & task performance although acute subjective responses to alcohol are biphasic, effects on psychomotor performance appear to be linear
i.e. even low-to-moderate doses (which may be subjectively stimulating) can impair task performance
impairment in psychomotor tasks (simple & choice reaction time, vigilance) is evident before subject is drunk and at BAC levels that are below the legal driving limit
impairment increases with increasing dose -
32. Effects at different blood alcohol concentrations (BAC in grams of alcohol per litre of blood)
33. Alcohol & task performance performance is most affected on more complex tasks (see Kerr & Hindmarch, 1998)
so a low dose that doesnt impair performance on simple psychomotor tasks may still have a negative effect on more complex tasks (e.g. driving)
alcohol also produces anterograde amnesia in memory tasks
34. Effects of 0.8g/kg alcohol on Tower of London task: ITT = log. initial thinking time, STT = log. subsequent thinking time (from Weissenborn & Duka 2003, Psychopharmacology 165, 306-312)
35. Alcohol & TOL task - Weissenborn & Duka (2003) all differences are p<.05
time to first move (ITT) is shorter in subjects given alcohol
but subsequent thinking times (STT) are longer
and fewer perfect solutions are achieved
shorter ITT may reflect increased impulsivity
mean BAC in alcohol group at time of testing was < 0.6 g/l
legal driving limit is 0.8 g/l
36. Glutamate & GABA - summary glutamate - the principal excitatory NT in the brain
NMDA glutamate receptors have an important role in learning & memory, schizophrenia & addiction
ketamine NMDA receptor antagonist that produces acute dissociation & schizophrenic-like symptoms
GABA - the principal inhibitory NT in the brain
GABA agonists (benzodiazepines, barbiturates, alcohol) have anxiolytic, sedative & hypnotic effects
benzodiazepines are the most widely prescribed psychoactive drugs in the world; used to treat anxiety & insomnia, side-effects include impaired reaction time, attention & memory
alcohol is both a GABA agonist & a glutamate antagonist
long-term alcohol abuse alters balance of inhibitory/excitatory neurotransmission, which can lead to alcohol dependence & withdrawal syndromes
acute subjective effects of alcohol are biphasic (low doses feel stimulating, high doses sedating), but even low doses can impair cognitive performance especially on complex tasks (problem solving, driving)
37. Learning outcomes Be able to describe the acute effects of ketamine intoxication, and how these are related to the positive and negative symptoms of schizophrenia.
Know the main conditions for which benzodiazepine drugs are prescribed, and understand the neuro-chemical basis of the therapeutic effects and side-effects of these drugs.
Understand the psychopharmacological basis for the acute effects of alcohol, and the mechanisms underlying alcohol dependence and withdrawal syndromes.
38. Recommended reading GLUTAMATE & KETAMINE
JW Newcomer et al (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20, 106-118
EB Perry et al (2007) Psychiatric safety of ketamine in psycho-pharmacology research. Psychopharmacology 192, 253-260
GABA & ANXIOLYTICS
HV Curran (1999) Effects of anxiolytics on memory. Human Psychopharmacology 14, S72-S79
JC Verster et al (2002) Effects of alprazolam on driving ability, memory functioning and psychomotor performance. Neuropsychopharmacology 27, 260-269
39. ALCOHOL
JS Kerr & I Hindmarch (1998) The effects of alcohol alone or in combination with other drugs on information processing, task performance and subjective responses. Human Psychopharmacology 13, 1-9
CF Valenzuela (1997) Alcohol and neurotransmitter interactions. Alcohol Health & Research World 21, 144-148